Genocea Biosciences
Cambridge, US · 2 known investors
Uses a T-cell antigen discovery platform to develop vaccines for oncology and infectious disease.
Biotech
Founders & leadership
NS
Narinder SinghExecutive Officer
DM
Derek MeisnerExecutive Officer
MA
Michael AlfieriExecutive Officer
KB
Katrine BosleyDirector
JF
Jessica FlechtnerExecutive Officer
AB
Ali BehbahaniDirector
GA
Girish AakaluExecutive Officer
RC
Ronald CooperDirector
MH
Michael HigginsDirector
TD
Thomas DavisExecutive Officer
GS
George SiberDirector
WC
William ClarkExecutive Officer
Investors · 2
Reported raises · per SEC filings
Form D private placements$75.5MraisedAug 2020 · 18 investors · Biotechnology
Rule 506(b)$12.1MraisedFeb 2019 · 9 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.